Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015', http://bit.ly/29QFXPp


In this issue


Home Eurosurveillance Edition  2016: Volume 21/ Issue 50 Article 6
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 21, Issue 50, 15 December 2016
Letter
Pharris, Quinten, Noori, Amato-Gauci, and van Sighem: Authors' reply: New metrics to monitor progress towards global HIV targets: using the estimated number of undiagnosed HIV-infected individuals as denominator

+ Author affiliations


Citation style for this article: Pharris A, Quinten C, Noori T, Amato-Gauci AJ, van Sighem A. Authors' reply: New metrics to monitor progress towards global HIV targets: using the estimated number of undiagnosed HIV-infected individuals as denominator. Euro Surveill. 2016;21(50):pii=30428. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.50.30428

Received:13 December 2016; Accepted:15 December 2016

To the Editor: We thank Dr Sasse for his interest in the conclusions of our rapid communication, in which we used the European Centre for Disease Prevention and Control (ECDC) HIV Modelling tool to estimate for the number and proportion of persons living with HIV who remain undiagnosed in the European Union/European Economic Area [1]. In response to our discussion of the limitations of monitoring a proportion of those undiagnosed relative to persons diagnosed and living with HIV, because this will naturally decrease over time as the number of those undiagnosed becomes smaller in relation to the growing number of persons diagnosed and living longer with HIV, Dr Sasse proposes a new metric: the yearly diagnosed fraction (YDF), where diagnoses made in a given year are examined in relation to the number of persons undiagnosed [2]. We agree that the YDF is an interesting proposal which has the potential to inform monitoring of HIV testing programme efforts. However, it should be remembered that metrics based on estimates are not always straightforward to monitor over time. Estimates can change slightly from year to year, depending on data sources and assumptions used in the model, and changes in the YDF should be interpreted with this in mind, and including confidence intervals to understand the range of uncertainty in a given year.


Conflict of interest

None declared.

Authors’ contributions

All authors drafted the reply.


References

  1. Pharris A, Quinten C, Noori T, Amato-Gauci AJ, van Sighem A, ECDC HIV/AIDS Surveillance and Dublin Declaration Monitoring Networks. Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015.Euro Surveill. 2016;21(48):30417. DOI: 10.2807/1560-7917.ES.2016.21.48.30417 PMID: 27934585

  2. Sasse A. Letter to the editor: New metrics to monitor progress towards global HIV targets: using the estimated number of undiagnosed HIV-infected individuals as denominator.Euro Surveill. 2016;21(50):30424. DOI: 10.2807/1560-7917.ES.2016.21.50.30424



Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.